Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

Figure 3

One way sensitivity analysis tornado diagram ICER results. CI: confidence interval; PEM: pemetrexed; DOC: docetaxel; AE: adverse events; FN: febrile neutropenia; BSC: best supportive care

Results from the one way sensitivity analysis demonstrate that the model is primarily sensitive to the 95% CI for the survival hazard ratio comparing pemetrexed versus docetaxel.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us